Showing results (41-50 of 237) with videos related to
Sort By:
Pageof 24
Frontiers in Oncology|January 4, 2021
Vitamin D Status and Survival in Stage II-III Colorectal CancerYichao Bao, Yaqi Li, Yan Gong, et al.Plos One|April 5, 2014
Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER databaseQingguo Li, Guoxiang Cai, Dawei Li, et al.Cancer Biomarkers : Section a of Disease Markers|December 11, 2012
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancerYuanming Lu, Gao Jingyan, Song Baorong, et al.International Journal of Colorectal Disease|March 17, 2018
The effect of marital status by age on patients with colorectal cancer over the past decades: a SEER-based analysisYang Feng, Weixing Dai, Yaqi Li, et al.Molecular Cancer|May 1, 2015
High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinomaXinxiang Li, Lei Liang, Liyong Huang, et al.Analytical Chemistry|August 7, 2008
ZnO-poly(methyl methacrylate) nanobeads for enriching and desalting low-abundant proteins followed by directly MALDI-TOF MS analysisWenwen Shen, Huanming Xiong, Ye Xu, et al.International Journal of Colorectal Disease|May 18, 2018
Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancerQi Liu, Yanlei Ma, Dakui Luo, et al.American Journal of Cancer Research|November 27, 2015
High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcomeQingguo Li, Xianke Meng, Lei Liang, et al.Biomed Research International|February 21, 2020
Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK-eIF2α SignalingHongtu Zheng, Yuchen Wu, Tianan Guo, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 27, 2015
[The differences between three distinct locations of colorectal cancers based on clinicopathological characteristics and molecular features]Cong Li, Zhimin Wang, Jiang Zhao, et al.Pageof 24